S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

リアルタイムの更新: Pfizer Inc [PFE.DE]

取引所: XETRA セクター: Pharmaceuticals 産業: Drug Manufacturers—General
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-04-29)

Expected move: +/- 0.00%

最終更新日時27 4月 2024 @ 00:35

-0.25% 23.79

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 00:35):

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands...

Stats
本日の出来高 70 820.00
平均出来高 92 922.00
時価総額 134.31B
EPS €0 ( 2024-01-30 )
次の収益日 ( €0 ) 2024-04-29
Last Dividend €0.410 ( 2023-07-27 )
Next Dividend €0 ( N/A )
P/E 69.96
ATR14 €0.0470 (0.20%)

ボリューム 相関

長: 0.03 (neutral)
短: 0.59 (weak)
Signal:(51.925) Neutral

Pfizer Inc 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Pfizer Inc 相関 - 通貨/商品

The country flag 0.07
( neutral )
The country flag 0.14
( neutral )
The country flag 0.00
( neutral )
The country flag 0.19
( neutral )
The country flag -0.44
( neutral )
The country flag -0.11
( neutral )

Pfizer Inc 財務諸表

Annual 2023
収益: €58.50B
総利益: €33.54B (57.34 %)
EPS: €0.380
FY 2023
収益: €58.50B
総利益: €33.54B (57.34 %)
EPS: €0.380
FY 2022
収益: €100.33B
総利益: €65.99B (65.77 %)
EPS: €5.63
FY 2021
収益: €81.29B
総利益: €50.47B (62.08 %)
EPS: €3.95

Financial Reports:

No articles found.

Pfizer Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0.400
(N/A)
€0.400
(N/A)
€0.410
(N/A)
€0.410
(N/A)
€0.410
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Pfizer Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.07 - average (69.29%) | Divividend Growth Potential Score: 4.08 - Stable (18.42%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.325 2008-01-11
Last Dividend €0.410 2023-07-27
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 68 --
Total Paid Out €20.64 --
Avg. Dividend % Per Year 0.00% --
Score 3.7 --
Div. Sustainability Score 6.07
Div.Growth Potential Score 4.08
Div. Directional Score 5.07 --
Next Divdend (Est)
(2024-07-08)
€0.419 Estimate 22.38 %
Dividend Stability
0.60 Average
Dividend Score
3.70
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
ZEG.DE Ex Dividend Knight 2023-08-10 Semi-Annually 0 0.00%
GDX.DE Ex Dividend Knight 2023-10-05 Quarterly 0 0.00%
PPX.DE Ex Dividend Knight 2023-05-02 Semi-Annually 0 0.00%
BC8.DE Ex Dividend Knight 2023-05-26 Annually 0 0.00%
I93.F Ex Dividend Junior 2023-08-28 Quarterly 0 0.00%
SMHN.DE Ex Dividend Junior 2023-06-01 Annually 0 0.00%
COP.DE Ex Dividend Knight 2023-05-18 Annually 0 0.00%
LAR.DE Ex Dividend Knight 2023-09-12 Quarterly 0 0.00%
UNP.DE Ex Dividend Knight 2023-08-30 Quarterly 0 0.00%
EBO.DE Ex Dividend Junior 2023-05-16 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.03671.5009.2710.00[0 - 0.5]
returnOnAssetsTTM0.009471.2009.6810.00[0 - 0.3]
returnOnEquityTTM0.02221.500-0.864-1.296[0.1 - 1]
payoutRatioTTM4.31-1.00010.00-10.00[0 - 1]
currentRatioTTM0.9070.800-0.467-0.373[1 - 3]
quickRatioTTM0.5830.800-1.279-1.023[0.8 - 2.5]
cashRatioTTM0.05971.500-0.779-1.169[0.2 - 2]
debtRatioTTM0.313-1.5004.79-7.18[0 - 0.6]
interestCoverageTTM0.5511.000-0.907-0.907[3 - 30]
operatingCashFlowPerShareTTM1.5552.009.4810.00[0 - 30]
freeCashFlowPerShareTTM0.8562.009.5710.00[0 - 20]
debtEquityRatioTTM0.796-1.5006.82-10.00[0 - 2.5]
grossProfitMarginTTM0.4791.0005.365.36[0.2 - 0.8]
operatingProfitMarginTTM0.02081.000-1.584-1.584[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1231.000-0.429-0.429[0.2 - 2]
assetTurnoverTTM0.2580.800-1.612-1.289[0.5 - 2]
Total Score6.07

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM66.391.0003.390[1 - 100]
returnOnEquityTTM0.02222.50-0.555-1.296[0.1 - 1.5]
freeCashFlowPerShareTTM0.8562.009.7110.00[0 - 30]
dividendYielPercentageTTM6.481.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.5552.009.4810.00[0 - 30]
payoutRatioTTM4.311.50010.00-10.00[0 - 1]
pegRatioTTM-2.391.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1491.0008.780[0.1 - 0.5]
Total Score4.08

Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。